Gastrointestinal cancers – still many questions to be resolved

Thaler J, Resch G. Adjuvant therapy in colon carcinoma stages II and III. memo, 4(2): 86–89, 2011 Hoffmann W, Lordick F, Becker-Schiebe M. (Neo-) Adjuvant Radio Chemotherapy in stage II/III Rectal cancer. memo, 4(2): 90–93, 2011 Hacker UT, Coutelle O, Hallek M. Recent developments and future persepectives in systemic treatment of metastatic colorectal cancer. memo, 4(2): 75–78, 2011 Zitt M, Bowel first? simultaneous resection? Liver First? Treatment options in patients with colorectal cancer and resectable synchronous liver metastases. memo, 4(2): 79–81, 2011 Bale R, Widmann G. Can radiofrequency ablation replace liver resection? memo, 4(2): 82–85, 2011 Gabriel M. Contribution of PET-CT in the management of GI-cancer. memo, 4(2): 102–104, 2011 Ruhstaller T, Stahl M. Current treatment strategies of esophageal carcinoma. memo, 4(2): 66–70, 2011 Lordick F, Schumacher G, Becker-Schiebe M. Gastric Cancer. memo, 4(2): 71–74, 2011 Köberle D, Samaras P. Recent advances and future challenges in the treatment of hepatocellular and biliary tract carcinomas. memo, 4(2): 94–97, 2011 Becker-Schiebe M, Lordick F, Hoffmann W. Side-effect management during. treatment of GI-cancers. memo, 4(2): 98–101, 2011